MiniMed Group, Inc.(MMEDV)

Medical - Instruments & Supplies · Northridge, CA

$20.000.00 (0.00%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

MiniMed Group (MMEDV) EBITDA Yield: History & Chart | TGMCharts

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T20:32:14.471Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:32:14.471Z.

Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA: N/A
Quote market capitalization: 560,000,000
Total debt: N/A
Cash: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MMEDV EBITDA Yield Metrics

EBITDA YIELD

N/A

MMEDV Competitors' EBITDA Yield

MMEDV

MiniMed Group, Inc.

Current

Market Cap

$560.00M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTMX

CytomX Therapeutics, Inc.

vs MMEDV

Market Cap

$557.32M

EBITDA Yield

N/A

TTM Avg

31.68%

3Y Avg

26.65%

5Y Avg

26.65%

CRMD

CorMedix Inc.

vs MMEDV

Market Cap

$571.13M

EBITDA Yield

54.86%

TTM Avg

22.76%

3Y Avg

17.21%

5Y Avg

17.21%

PHAT

Phathom Pharmaceuticals, Inc.

vs MMEDV

Market Cap

$548.51M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AQST

Aquestive Therapeutics, Inc.

vs MMEDV

Market Cap

$578.40M

EBITDA Yield

N/A

TTM Avg

2.38%

3Y Avg

2.38%

5Y Avg

2.38%

PROK

ProKidney Corp.

vs MMEDV

Market Cap

$538.01M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KIDS

OrthoPediatrics Corp.

vs MMEDV

Market Cap

$583.31M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FLGT

Fulgent Genetics, Inc.

vs MMEDV

Market Cap

$584.48M

EBITDA Yield

N/A

TTM Avg

41.20%

3Y Avg

25.05%

5Y Avg

21.67%

MNPR

Monopar Therapeutics Inc.

vs MMEDV

Market Cap

$533.04M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCTH

Delcath Systems, Inc.

vs MMEDV

Market Cap

$531.98M

EBITDA Yield

N/A

TTM Avg

1.23%

3Y Avg

1.23%

5Y Avg

1.23%

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
MiniMed Group, Inc. (MMEDV)	$560.00M	N/A	N/A	N/A	N/A
CytomX Therapeutics, Inc. (CTMX)vs ›	$557.32M	N/A	31.68%	26.65%	26.65%
CorMedix Inc. (CRMD)vs ›	$571.13M	54.86%	22.76%	17.21%	17.21%
Phathom Pharmaceuticals, Inc. (PHAT)vs ›	$548.51M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$578.40M	N/A	2.38%	2.38%	2.38%
ProKidney Corp. (PROK)vs ›	$538.01M	N/A	N/A	N/A	N/A
OrthoPediatrics Corp. (KIDS)vs ›	$583.31M	N/A	N/A	N/A	N/A
Fulgent Genetics, Inc. (FLGT)vs ›	$584.48M	N/A	41.20%	25.05%	21.67%
Monopar Therapeutics Inc. (MNPR)vs ›	$533.04M	N/A	N/A	N/A	N/A
Delcath Systems, Inc. (DCTH)vs ›	$531.98M	N/A	1.23%	1.23%	1.23%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

MMEDV EBITDA Yield Metrics

MMEDV Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics